Read more

December 30, 2022
1 min read
Save

Top in GI: Plant-based diet and colorectal cancer risk; Constipation Awareness Month

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A plant-based diet was associated with an overall reduced risk for colorectal cancer, although the findings varied by race and ethnicity as well as tumor site, according to researchers.

They said that more research is needed to further investigate factors that may influence the association between plant-based foods and cancer risk. It was the top story in gastroenterology last week.

Vegetables 2019 Adobe
A plant-based diet was associated with an overall reduced risk for colorectal cancer, although the findings varied by race and ethnicity as well as tumor site, according to researchers. Source: Adobe Stock

Another top story was a roundup of Healio’s constipation-related news throughout 2022 for Constipation Awareness Month. The stories include meeting coverage from the ACG Annual Scientific Meeting and Digestive Disease Week and research published in gastroenterology journals on new pharmacological medications and electrical stimulation.

Read these and more top stories in gastroenterology below:

Future research needed to investigate link between plant-based food intake, CRC

A plant-based diet rich in whole grains, vegetable and legumes was associated with a reduced risk for colorectal cancer in a multiethnic cohort of men but varied by race, ethnicity and site of tumor, according to research in BMC Medicine. Read more.

Constipation Awareness Month: Potential breakout therapies to watch in 2023

Chronic constipation affects up to 20% of adults and 16% of children in the U.S, therefore the International Foundation for Gastrointestinal Disorders recognized December as Constipation Awareness Month. Read more.

Although cure rates with DAAs top 97%, less than two-thirds of patients receive treatment

Less than two-thirds of insured patients with viremic hepatitis C virus infection received treatment with direct-acting antivirals from 2014 to 2021, with a sharp decline in diagnoses and treatment reported during the COVID-19 pandemic. Read more.

FDA agrees on Abivax’s pediatric study plan to develop obefazimod for children with IBD

The FDA has agreed on Abivax’s initial pediatric study plan for the development of obefazimod in children aged 2 to 17 years with inflammatory bowel disease, the company announced in a press release. Read more.

Sustained alcohol abstinence benefits even advanced cases of alcohol-related cirrhosis

Abstinence from alcohol was associated with reduced risk for hepatic decompensation and mortality among patients with alcohol-related cirrhosis, regardless of disease stage, according to results in Clinical Gastroenterology and Hepatology. Read more.